Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease: Specific differences to vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 12, Issue 2, 2001, Pages 98-105

  Eckert, Anne ^a,b   Oster, Manfred ^a   Zerfass, Richard ^a   Hennerici, Michael ^a   Müller, Walter E ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Apoptosis; Cerebrovascular disorders; Dementia; Lymphocytes; Oxidative stress

Indexed keywords

DNA; DNA FRAGMENT; INTERLEUKIN 2;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BLOOD CELL; BRAIN DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NUCLEOSOME; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOPTOSIS; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DISEASE SUSCEPTIBILITY; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NUCLEOSOMES; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY;

EID: 0035121632     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051242     Document Type: Article

References (48)

1. DNA strand breaks in Alzheimer's disease
2. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
3. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
4. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures
5. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35
6. Hydrogen peroxide mediates amyloid beta protein toxicity
7. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons
8. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells
9. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals
10. Lymphocytes as cell model to study apoptosis in Alzheimer's disease: Vulnerability to programmed cell death appears to be altered
11. Enhanced vulnerability to apoptotic cell death in sporadic Alzheimer's disease
12. The diagnosis of vascular dementia in the light of the new criteria
13. Are gait disturbances and white matter degeneration early indicators of vascular dementia?
14. Impaired calcium regulation in subcortical vascular encephalopathy
15. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
16. Psychotic features and the course of Alzheimer's disease: Relationship to cognitive, electroencephalographic and computerized tomography findings
17. Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients
18. Variability of vascular territory in stroke. Pitfalls and failure of stroke pattern interpretation
19. Epileptic seizures in subcortical vascular encephalopathy
20. Assessment of T2-and T1-weighted MRI brain lesion load in patients with subcortical vascular encephalopathy
21. Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop
22. Admission criteria for immunogerontological studies in man. The SENIEUR protocol
23. Beta-amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes
24. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
25. D-Ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells
26. Altered apoptosis in lymphocytes from sporadic Alzheimer's disease patients
27. Differences in dexamethansone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia
28. The highly reducing sugar 2-deoxy-D-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption
29. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology
30. Amyloid beta-peptide is produced by cultured cells during normal metabolism
31. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation
32. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: Central roles of superoxide production and caspase activation
33. Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells
34. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor
35. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease
36. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alz-heimer's disease
37. Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease
38. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice
39. Enhanced vulnerability to cell death in lymphocytes from PS-1 mutant transgenic mice
40. Age-related changes of apoptotic cell death in human lymphocytes
41. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease
42. Oxidative damage to DNA in lymphocytes from AD patients
43. Abrogation of the presenilin 1/beta-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation
44. Enhanced cytotoxic response of natural killer cells to interleukin-2 in Alzheimer's disease
45. IL-2 and IL-6 secretion in dementia: Correlation with type and severity of disease
46. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases
47. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
48. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis